SCHEMBL5572097

SCHEMBL5572097

CC(Oc1cccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12)C(=O)N1CCOCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 20/20 1.00
KCNH2 Q12809 7/20 1.00
EGFR P00533 8/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5635979 1.00 ERBB2 (1.00) ERBB2KCNH2EGFR
SCHEMBL5634939 0.93 ERBB2 (0.88) ERBB2KCNH2EGFR
SCHEMBL5568342 0.93 ERBB2 (0.88) ERBB2KCNH2EGFR
SCHEMBL5570471 0.92 ERBB2 (0.85) ERBB2KCNH2EGFR
SCHEMBL5637026 0.92 ERBB2 (0.85) ERBB2KCNH2EGFR
SCHEMBL5636565 0.90 ERBB2 (0.82) ERBB2KCNH2EGFR
SCHEMBL5635649 0.90 ERBB2 (0.81) ERBB2KCNH2EGFR
SCHEMBL5566608 0.88 ERBB2 (0.79) ERBB2KCNH2EGFR
SCHEMBL5635992 0.88 ERBB2 (0.79) ERBB2KCNH2EGFR
SCHEMBL5569876 0.88 ERBB2 (0.79) ERBB2KCNH2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756088-A1 QUINAZOLINE DERIVATIVES AS ERBB RECEPTOR TYROSINE KINASES AstraZeneca AB (SE) 2007-02-28 EP disclosed
WO-2005118572-A1 QUINAZOLINE DERIVATIVES AS ERBB RECEPTOR TYROSINE KINASES ASTRAZENECA AB (SE) 2005-12-15 WO disclosed